Mary Kemeny

Search results

• CDRH: EMERGING CANCER BLOOD TEST CONCERNS BEYOND FDA'S AUTHORITY

  Kemeny, M.

  7/12/23

  1 item of Media coverage

  Press/Media

• CDRH: Concerns Over Emerging Cancer Blood Tests Beyond The Scope Of FDA Authorities

  Kemeny, M.

  6/12/23

  1 item of Media coverage

  Press/Media

• CDRH: CANCER BLOOD TESTS ISSUES BEYOND THE SCOPE OF FDA AUTHORITIES

  Kemeny, M.

  1/12/23

  2 items of Media coverage

  Press/Media